Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
This is the UK arm of a clinical trial of the vaccine (GRT-R910) produced by US-based biotechnology company Gritstone bio, Inc.
The trial will involve 20 people aged 60 and over, who previously received two doses of the AstraZeneca vaccine, and will take place at the NIHR Manchester Clinical Research Facility at Manchester Royal Infirmary, part of Manchester University NHS Foundation Trust (MFT).
Health Innovation Manchester